ÂÜÀòÂÒÂ×

David has more than two decades of experience in corporate development, strategic planning, commercialization and operations across multiple sectors in the life sciences industry. He most recently served as Chief Business Officer of Aldeyra Therapeutics, a Nasdaq listed biotechnology company. In addition to his role at nference, he also serves at Chief Business Officer at Anumana, a new company from nference and Mayo Clinic.

Before Aldeyra, Mr. McMullin ran U.S. Internal Medicine at Shire plc, a $1.4 billion rare disease and specialty pharmaceutical company, and was previously the head of Global Commercial Operations at Shire. Prior to his work at Shire, he was the vice president of Global Supply Chain Management and Strategy at Novartis. He holds an MBA with high distinction as a Baker Scholar from Harvard University and a bachelor’s degree in Economics from Brigham Young University.